The ability of brown adipocytes (fat cells) to dissipate energy as heat shows great promise for the treatment of obesity and other metabolic disorders. Employing pluripotent stem cells, with an emphasis on directed differentiation, may overcome many issues currently associated with primary fat cell cultures. In addition, three-dimensional (3D) cell culture systems are needed to better understand the role of brown adipocytes in energy balance and treating obesity. To address this need, we created 3D "Brown-Fat-in-Microstrands" by microfluidic synthesis of alginate hydrogel microstrands that encapsulated cells and directly induced cell differentiation into brown adipocytes, using mouse embryonic stem cells (ESCs) as a model of pluripotent stem cells, and brown preadipocytes as a positive control. Brown adipocyte differentiation within microstrands was confirmed by immunocytochemistry and qPCR analysis of the expression of the brown adipocyte-defining marker uncoupling protein 1 (UCP1), as well as other general adipocyte markers. Cells within microstrands were responsive to a β-adrenergic agonist with an increase in gene expression of thermogenic UCP1, indicating that these "Brown-Fat-in-Micrtostrands" are functional. The ability to create "Brown-Fat-in-Microstrands" from pluripotent stem cells opens up a new arena to understanding brown adipogenesis and its implications in obesity and metabolic disorders.
Introduction
The thermogenic capacity of brown adipose tissue (BAT) has changed the general conception of fat [1, 2] . Originally, BAT remained "under the radar", as it was primarily associated with rodents, hibernating animals, and human infants where activated BAT is responsible for nonshivering thermogenesis during cold exposure [3] and diet-induced thermogenesis [4, 5] . However, BAT has become redefined by the recent confirmation of its existence and physiological significance in human adults [6] [7] [8] [9] [10] [11] [12] [13] [14] . This rediscovery has led to an influx of research concerning the role of BAT on the regulation of metabolic thermogenesis and thereby body fat content and triglyceride clearance [15, 16] . Moreover, it is the innate ability of BAT that generates heat via a tightly controlled and extremely energy-expensive process. As a result, BAT provides an enormous impact on energy balance, which presents a clear therapeutic target, especially for treating obesity and related metabolic disorders, such as type 2 diabetes and non-alcohol hepatic steatosis [17] [18] [19] [20] .
The main cause of obesity, and thus obesity-related disease, is an energy imbalance in which energy intake exceeds energy dissipation [6, 17, 18] . Thus, it is critical to understand adipocyte biology for the development of potential obesity treatment strategies. During the development of obesity, adipocytes can increase in size (hypertrophy) or in amount (hyperplasia) [21, 22] . Both cell conditions are known to occur in adolescents. However, adipocyte turnover is maintained at a steady state in adults [22] . The two main types of adipose tissue are white and brown adipose tissue [23] . White adipose tissue (WAT) is composed of unilocular white adipocytes, functions to store energy in the form of triglycerides, and acts as a vital endocrine and immune organ [24] [25] [26] [27] . On the contrary, BAT is composed of multilocular brown adipocytes containing abundant mitochondria, and is specialized to expend energy as heat by uncoupling the synthesis of ATP from the electron transport chain with its unique mitochondrial membrane embedded protein, uncoupling protein 1 (UCP1) [24, [28] [29] [30] [31] [32] . A new type of thermogenic adipocytes, known as beige, brite (brown in white), or inducible brown adipocytes, have been recently identified within white fat depots, named as such because they can be induced into brown-like adipocytes [9, [33] [34] [35] [36] [37] [38] , thereby representing the plasticity of adipocytes [39] . Brown and beige fat can be activated by stimulation through cold exposure, receptor activation, exercise, hormone treatment (e.g., irisin, FGF21) or microRNA networks [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] . Similar to BAT, beige adipocytes express UCP1 and possess thermogenic capacity upon induction [18, 36, 55, 56] .
Although there is great potential for BAT to correct the energy imbalance in obese individuals, there are still many challenges to overcome prior to clinical applications. These include the need for an adequate cellular model system of human adipose tissue, as well as an effective implantation method. Although primary culture and differentiation of human adipocyte precursors have been used to understand adipocyte biology, these cells are difficult to obtain, culture, and expand in vitro [1] , and fail to fully recapitulate human adipocyte development [57] and metabolic processes [58] . Pluripotent stem cells, including embryonic stem cells (ESCs) and induced pluripotent stem cells, provide a good model system for understanding early events in development [59] [60] [61] as well as an unlimited source of white, brown, and beige adipocytes [25, [62] [63] [64] . The feasibility of generating brown or white adipocytes from human pluripotent stem cells has been demonstrated with up to 85-90% differentiation efficiency through cellular programming and transplantation techniques [25, 58] . However, this approach includes multiple steps and relies on transferring exogenous genes to derive adipocytes from pluripotent stem cells. For instance, human pluripotent stem cells are first differentiated into mesenchymal progenitor cells through embryoid body (EB) formation, followed by replating of EBs on gelatin-coated tissue culture dishes. Then, these mesenchymal progenitor cells are replated again and transduced with a lentivirus constitutively expressing the regulator genes of white or brown adipogenesis, respectively, followed by the addition of adipogenic factors such as insulin, dexamethasone, and rosiglitazone. In order to differentiate human pluripotent stem cells into functional, classic brown adipocytes without gene transfer, a specific hematopoietic cytokine cocktail has been used [63, 65] . Differentiation in this manner also includes the formation of EB-like spheres as the very first step, and replating of these spheres on gelatincoated tissue culture plates thereafter. Taken together, data from these techniques suggest that it would be beneficial to recreate a three-dimensional (3D) microenvironment for pluripotent stem cell differentiation and adipogenesis in vitro [66] , including BAT formation. Additionally, although BAT transplantation has been demonstrated for decades [67] , cell necrosis often occurs upon transplantation of free fat, resulting in poor formation of microvascular networks and graft resorption [68, 69] . Altogether, there is a great need for a 3D culture system that could recreate the microenvironment for BAT differentiation from pluripotent stem cells, recapitulating BAT function during in vitro culture, and provide a new vehicle to improve the stability and engraftment efficiency during in vivo BAT transplantation.
We envision that cell encapsulation in alginate hydrogel microstrands could offer an effective 3D culture solution to address the needs for BAT differentiation and transplantation. Alginate is an FDA-approved biomaterial that has been demonstrated to be safe for drug delivery, stem cell culture, tissue engineering, and cell therapy [70] [71] [72] [73] . The long tubular structure and small diameter (200 µm) of alginate hydrogel microstrands can easily overcome the diffusion limitation that challenges the use of hydrogel microbeads for cell implantation [74] , which allows for more efficient signaling, nutrient and oxygen exchanges, and support for high cellularity of stem cells grown in the tubular structure [75, 76] . Additionally, these microstrands are easy to be handled for in vivo delivery by injection or implantation while maintaining their structural integrity. Moreover, alginate hydrogel microstrands exhibit great potential for reconstituting intrinsic morphologies and functions of living tissues [77, 78] . The current approaches to fabricate hydrogel microstrands include utilizing coaxial flow and a microfluidic chip [79] , flowing through a microfabricated SU-8 filter by a variety of techniques, including capillary force [75, 76] , wet spinning [80] , composite techniques [81] . Here, we present a new microfluidic approach for cell encapsulation in alginate hydrogel microstrands, by simply driving an alginate solution to flow consistently into a calcium solution.
In this study, we create "Brown-Fat-in-Microstrands" by encapsulating brown preadipocytes and pluripotent stem cells in 3D alginate hydrogel microstrands, and directly differentiating them into functional brown adipocytes. Mouse embryonic stem cells (ESCs) are used as model of pluripotent stem cells to test the feasibility of 3D brown adipogenesis in alginate microstrands. Mouse WT-1 brown preadipocytes are also grown within the same system to serve as a positive control. We culture cells within the alginate hydrogel microstrand system, and then expose them to a brown adipogenic differentiation scheme. We then assess the expression of characteristic brown adipogenesis markers, compare to 2D differentiation, and test for functional responsiveness. This bioengineered "Brown-Fat-in-Microstrands" has great potential to serve as an in vitro culture system for understanding brown adipogenesis, an in vitro assay for testing the efficacy of treatment, and as a stable, functional brown fat depot for in vivo implantation.
Materials and Methods

ES cell culture
The mouse CCE ES cell line was provided by StemCell Technologies, Inc. (Vancouver, Canada) [82, 83] . Cells were cultivated in gelatin-coated tissue culture flasks and maintained in an undifferentiated state using maintenance medium. This maintenance medium consisted of Dulbecco's Modified Eagle's Medium (DMEM 4.5 g/l D-glucose), enhanced with 15% (v/v) fetal bovine serum (FBS), 10 ng/ml murine recombinant leukemia inhibitory factor (LIF; StemCell Technologies), 0.1 mM non-essential amino acids, 0.1 mM monothioglycerol, 100 U/ml penicillin, 100 µg/ml streptomycin, and 2 mM L-glutamine, and 1 mM sodium pyruvate (Sigma-Aldrich, St Louis, MO).
WT-1 preadipocyte culture
Murine WT-1 preadipocyte line was provided by Dr. Yu-Hua Tseng (Joslin Diabetes Center, Harvard Medical School Affiliate, Boston, MA). The cells were cultured following a previously established protocol [84, 85] . Briefly, WT-1 preadipocytes were propagated in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin. When the cells were ready to be split for experimentation, 0.1 µg/mL insulin and 10 −8 µM T3 were added to the maintenance medium to begin the differentiation process on day 1 (this medium will be referred to as differentiation medium). To induce differentiation into brown adipocytes, at 4day postconfluence, cells were treated with DMEM containing 10% FBS, 125 µM indomethacin, 1 µM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, 0.1 µg/ml insulin, and 10 −8 µM triiodothyronine (T3) (Sigma-Aldrich). The cells were incubated in this induction medium for day 5, and then refed with the differentiation medium on days 6 and 8 to be ready for characterization by day 10.
Fabrication of alginate microstrands containing ESC and WT-1 cells
One million mouse ESCs were suspended in 1 mL of 1.5% alginate (made from sodium alginate from brown algae with a viscosity of 100-300 cP in 2% solution at 25 °C, Sigma-Aldrich) in physiological saline solution at 37°C. This ESC-alginate suspension was then loaded into a syringe in a pump set to dispense 0.5 mL/hr. A capillary silica tip (diameter of 100-250 µm) was then attached to the end of the syringe via an adapter. The pump was then inverted so that the tip was downward facing, and then allowed to dispense for 1-5 minutes to calibrate. Dispensing without interruption was continued following calibration, with the tip being shaken to remove any possible alginate build-up, and then inserted into the calcium chloride solution (Sigma-Aldrich) within the well of a 24-well plate (Fig. 1 ). The timer was then set to 1-5 minutes, with constant shaking of the tip to prevent obstruction. After the first well was completed, the microstrands were imaged using an inverted microscope (Nikon Eclipse TS100) in order to confirm proper formation. After confirmation, the process was repeated for several more wells in order to obtain a sufficient number of microstrand samples. The gel core microstrands were simply formed by removing the extra calcium chloride solution after fabrication and adding the proper cell media to facilitate growth. The liquid core microstrands were formed by coating the alginate hydrogel microstrands with 0.05% poly-L-lysine (PLL) (Sigma-Aldrich) by constant rocking for 10 minutes, and then incubating with 1.6% sodium citrate (Sigma-Aldrich) for 3 minutes in order to sequester the alginate inside the alginate-PLL shell. The liquid core microstrands were then placed in the proper cell media to facilitate cell growth.
WT-1 preadipocytes were subcultured as usual, and resuspended in the same fashion as the ESCs. The only difference was that the WT-1 preadipocytes were suspended at three times the density of the ESCs within the alginate (3×10 6 cells/mL). Characterization was extended past day 10 so that the WT-1 preadipocytes had sufficient time to grow and differentiate within the alginate microstrands.
Differentiation scheme of mESCs into brown adipocytes to create "Brown-Fat-in-Microstrands"
After the cells were encapsulated within the microstrands, they were incubated with cultivation medium (Iscove's Modified Dulbecco's Medium, 2 mM L-glutamine, 0.1 mM MEMs amino acids, 10% heat inactivated FBS, and 100 µM β-mercaptoethanol, (FBS is from Fisher Scientific, all other materials from Sigma-Aldrich) for the first two days. After this initial incubation, the untreated control group remained in cultivation medium whereas the differentiation group was treated with 10 −8 M retinoic acid (RA) (Sigma-Aldrich) for 4 days. After a day of rest, the ESC-hydrogel microstrands were exposed to 3.3 nM BMP7 for 4 days. At this point, the cells should be at the brown preadipocyte stage, and were then induced into brown adipocytes using Adipocyte Induction Medium (cultivation medium supplemented with 5 µM dexamethasone, 125 µM indomethacin, 0.5 mM 3-isobutyl-1methylxanthine (IBMX), 1 nM T3, and 20 nM insulin) (Sigma-Aldrich) for 3 days. In order to ensure the maturity of the brown adipocytes, they were maintained in differentiation medium (cultivation medium supplemented with 1 nM T3 and 20 nM insulin) with regular changing of the differentiation medium every 2 days. After 4 weeks "Brown-Fat-in-Microstrands" were established.
Oil Red O staining
A working solution of oil red O (Sigma-Aldrich) was prepared by mixing the stock solution (15 mg of oil red O dissolved for 1-2 hours in 50 mL of 99% isopropanol (Fisher Scientific, Waltham, MA)) in distilled water in a ratio of 6 parts stock to 4 parts water.
Both the control and differentiation group cells-in-microstrands were washed with physiological saline and then stained in the working solution of oil red O for 6-15 minutes. The background was then cleared with 60% isopropanol and the cells-in microstrands were washed a second time in physiological saline and imaged using a brightfield microscope (Nikon Eclipse TS100).
Immunocytochemistry analysis of brown and adipocyte-defining markers
In order to determine if the mouse ESCs have properly differentiated into brown adipocytes, immunocytochemistry analysis of UCP1 (brown adipocyte-defining marker), perilipin (surface marker of adipocytes) and PPARγ2 (adipocyte transcription factor) was performed. Mouse ESCs within the alginate microstrands were fixed using a 4% paraformaldehyde solution (Sigma-Aldrich), permeabilized using 0.2% Triton-X 100 (Sigma-Aldrich) in physiological saline, and blocked using 5% FBS in physiological saline (StemCell Technologies). Samples were incubated with the primary antibodies of perilipin (Santa Cruz Biotechnology, Inc., Dallas, Texas), PPARγ2 (Santa Cruz Biotechnology, Inc.), and brown adipocyte-defining UCP-1 (Santa Cruz Biotechnology, Inc.), at 4°C overnight or room temperature for 1 hour. The immunoreactivities were detected using secondary antibodies Alexa Fluor® 488 (perilipin) and Alexa Fluor® 647 (PPARγ2 or UCP1). Total cell population was revealed by staining cell nuclei with DAPI. All samples were imaged using the Leica Sp5 confocal microscope (Leica Microsystems, Wetzlar, Germany).
Quantitative Polymerase Chain Reaction
RNA was harvested from the samples using a combination of TRIzol® homogenization and chloroform phase separation (Life Technologies, Carlsbad, CA) followed by isolation using an RNeasy kit (Qiagen, Valencia, CA). The RNA samples were then reverse transcribed using a first-strand cDNA synthesis kit (Invitrogen, Grand Island, NY).
Quantitative real-time PCR (qPCR) analysis was performed using a StepOnePlus™ Real Time PCR system (Applied Biosystems, Foster City, CA). Samples were amplified using a SYBR® green I PCR master mix. Reactions were analyzed in triplicate and expression levels were normalized to the housekeeping gene ARBP. The relative quantitation of UCP1 in addition to a transcriptional regulator highly expressed in brown adipose tissue, PRDM16, and an adipocyte protein, aP2, were also determined using the comparative Ct method.
Functional analysis of "Brown-Fat-in-Microstrands"
In order to determine whether bioengineered "Brown-fat-in-Microstrands" were functional, responsiveness to the β-adrenergic agonist, isoproterenol (Sigma-Aldrich), was assessed. Briefly, 10 µM isoproterenol in cultivation medium was added to the "Brown-fat-in-Microtrands" and incubated at 37°C for 5 hours. Samples were then washed three times in 0.9% sodium chloride and further characterized by qPCR analysis for the brown adipogenic gene UCP1.
Statistical analysis
Data for qPCR analysis are presented as mean with standard deviation. Two-tailed Student's t-test was used to determine p values. Statistical significance was defined as p<0.05. Unser 
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Results
3D adipogenesis of WT-1 preadipocytes within alginate hydrogel microstrands
To demonstrate the feasibility of 3D adipogenesis, we have developed the microfluidic synthesis of alginate hydrogel microstrands ( Fig. 1) , followed by coating with poly-L-lysine to form a semipermeable membrane and then liquefying the gelled core with sodium citrate. In this way, WT-1 preadipocytes were successfully encapsulated in liquid core alginate microstrands with a diameter of 200 µm, induced to undergo brown adipogenesis, and cultured for 20 days.
Cells propagated in alginate microstrands, and maintained a dense cell mass after 11 days of cultivation, as observed under an optical microscope ( Fig. 2a-f ), which showed similar morphology to the undifferentiated sample set (data not shown). Adipogenic differentiation of WT-1 preadipocytes in alginate microstrands was initially confirmed by positive oil red O staining to show lipid accumulation in red ( Fig. 2g ) while the control group did not show positive oil red O staining ( Fig. 2h ).
To determine that differentiated WT-1 cells in alginate microstrands become brown fat cells, we have examined the expression of adipocyte markers (PPARγ2, perilipin), and a brown adipocyte marker (UCP1), using immunocytochemistry ( Fig. 3 ). Alginate hydrogel microstrands containing differentiated WT-1 cells on day 15 stained positively for adipocyte transcription factor PPARγ2 (Fig. 3a) , adipocyte surface marker perilipin ( Fig. 3b and e ), and brown adipocyte marker UCP-1 (Fig. 3d ), indicating that differentiated WT-1 cells in alginate microstrands acquire a brown adipocyte phenotype. Negative immunocytochemistry control for each secondary antibody was performed and showed no immunoreactivity, confirming that the immunoreactivity observed in differentiated samples was true ( Fig. 3g i). Additionally, brown WT-1 preadipocytes not exposed to the aforementioned differentiation scheme were used as undifferentiated control, showing no expression of adipocyte markers of PPARγ2 or perilipin, or brown adipocyte marker UCP-1. (Fig. 3j-o) . Although present, the weak level of expression inspired the extension of the WT-1 differentiation timeline to day 20 (Fig. 2f ) within alginate microstrands in order to ensure maturation of the brown adipocytes.
To further confirm the terminal differentiation of WT-1 cells into brown adipocytes within alginate microstrands beyond day 15, we quantified the expression of brown adipocyte genes (UCP1 and PRDM16) along with adipocyte genes (PPARγ2, PGC1α, and aP2) using qPCR. Both brown adipocyte genes UCP1 and PRDM16, as well as the adipocyte gene (aP2), were expressed at relatively higher levels in differentiated WT-1 cells within alginate microstrands (3D WT1 T) than in those of the control group, grown in 3D microstrands without brown adipogenic induction (3D WT1 C) ( Fig. 4 ). However, PPARγ2 and PGC1α were both expressed relatively lower in the 3D WT1 T than the 3D WT1 C samples. It is interesting to notice that the expression of PPARγ2 of brown adipocyte-differentiated WT-1 cells in alginate microstrands is higher than the undifferentiated control at protein level, but lower than that at mRNA level. These cumulative data demonstrate that WT-1 preadipocytes can grow and differentiate into characteristic brown adipocytes in alginate microstrands three dimensionally. 
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Direct differentiation of mouse ESCs within alginate hydrogel microstrands and creation of "Brown-Fat-in-Microstrands"
Next, we have developed a differentiation scheme to induce mouse ESCs in hydrogel microstrands directly into brown fat cells. Mouse ESCs were successfully encapsulated in alginate hydrogel microstrands. Our strategy to differentiate ESCs into brown fat cells includes i) driving ESCs to a mesenchymal stem cell (MSC)-like lineage by retinoic acid (RA) treatment, ii) deriving brown preadipocyte-like cells from MSCs by BMP-7 treatment, and iii) further inducing brown adipogenesis using brown adipocyte induction cocktails (Fig.  5a ).
Critical parameters of the microstrands were investigated to determine how microstrands should be created to optimize brown adipogenesis of mouse ESCs. In brown adipocytes, a dense cell mass formation is necessary because of the requirement of a high density of preadipocytes prior to induction. The first parameter explored was the interior environment; a liquid interior vs. a gel core, to determine which better produced the desired dense cell growth. Microstrands with a liquid core dramatically facilitated high-density cell growth, which is essential for adipogenesis induction (Fig. 5b ), while those with gel core retained ESCs as small cell aggregates (Fig. 5c ). Because adipose tissue is a dense tissue, it was important for the cells to have the ability to aggregate and form a dense cluster. In particular, contact inhibition when cells reach a high density is generally a prerequisite for the differentiation of preadipocytes. Therefore, microstrands with a liquid core were chosen for brown adipogenesis. In terms of the different microstrand diameters, both facilitated the growth of ESCs within microstrands into high-density colonies.
The second parameter tested was the diameter of the silica capillary tip. The tip diameters that were tested were 100-250 µm. Considering that the transport of oxygen, nutrients, and metabolic waste by diffusion becomes limited when the diffusion distance is over 200 µm [86, 87] , we chose to fabricate microstrands using a tip within the 100-200 µm range (compare Fig. 5d to 5e) for future experiments.
Finally, the concentration of bone morphogenetic protein 7 (BMP7) (R&D Systems Inc., Minneapolis, MN) was also explored. BMP7 is an essential component in the differentiation scheme presented in this work. The two concentrations tested were 3.3 and 8.3 nM. BMP7 plays an important role in stem cell differentiation to brown fat cells [88] . The decision between the concentrations of 3.3 and 8.3 nM BMP7 was expected to be easily determined by differences in lipid accumulation, qualitatively observed by oil red O staining. However, there was not a major difference between the two BMP7 concentrations ( Fig. 5f and g) . It has been reported that BMP7 at higher concentration might favor osteogenesis [89] [90] [91] . Therefore, we decided to pursue 3.3 nM BMP7 for future experiments.
Based on our aforementioned pilot studies, we have encapsulated mouse ESCs in liquid core alginate hydrogel microstrands with a diameter less than 200 µm, followed by differentiation as scheduled in Fig. 5a with 3 .3 nM BMP7. The time course of mouse ESCs grown within hydrogel microstrands during brown fat differentiation is shown in Fig. 5h -m. ESCs formed cell colonies in microstrands before day 3, and the aggregates of ESC colonies elongated with time, suggesting that the differentiation treatment did not affect cell growth. After 20 days of cultivation, differentiating ESCs tended to fully occupy the space in hydrogel microstrands, and exhibited lipid droplet accumulation as shown by oil red O staining at day 27 (Fig. 5n ).
We have confirmed that these differentiated ESCs in hydrogel microstrands expressed brown adipocyte-defining marker UCP1 along with general adipocyte markers using immunocytochemistry and qPCR analysis (Fig. 6a-i and Table 1 ). The expression of adipocyte transcription factor PPARγ2 (Fig. 6a ), adipocyte surface marker perilipin ( Fig. 6b and e) and, in particular, brown adipocyte defining marker UCP1 (Fig. 6d ) at the protein level indicated brown adipogenesis occurred.
The quantitative expression of brown adipocyte gene, UCP1 as well as PRDM16, and aP2 was determined using qPCR. As shown in Table 1 , the control group of mouse ESCs in microstrands without any induction of brown adipogenesis (3D CCE C) did not have any detectable expression of brown adipocyte genes. Directly-differentiated ESCs within hydrogel microstrands (3D CCE T) showed high levels of the brown adipocyte-defining gene UCP1 and PRDM16, indicating the formation of "Brown-Fat-in-Microstrands".
Comparison of 3D and 2D adipogenesis
To compare the degree of differentiation in our "Brown-Fat-in-Microstrands" to brown adipocyte differentiation of cells under monolayer conditions, we also differentiated mouse ESCs grown on glass (2D CCE T) using the differentiation scheme as shown in Fig. 5a . Brown adipocyte-defining marker UCP1 as well as PPARγ2, PGC1α, PRDM16 and aP2 were relatively expressed at higher levels than the undifferentiated ESCs (2D CCE C) ( Fig.  7a) , indicating that our differentiation scheme can drive ESCs grown on 2D into brown fat cells as well. When comparing 2D and 3D brown adipocyte-differentiated ESCs, we have noticed that 3D differentiated ESCs (3D CCE T) exhibited a significantly higher relative expression of UCP1, PGC1α and aP2 (Fig. 7b ). It is this increased relative expression of UCP1 that is especially worth highlighting, as it is the only gene in this that defines brown adipogenesis. However, the 3D differentiated ESCs did not appear to express PPARγ2 and PRDM16 any differently when compared to the 2D differentiated ESCs. In addition, the decreased expression of PPARγ2 and PGC1α in 2D CCE T compared to 2D CCE C was similar to that of the 3D WT-1 brown preadipocytes discussed in Fig. 4 . This could indicate that the long-term culture could be spontaneously differentiating the "control" into adipocytes. This was tested by examining the relative expression of UCP1, PPARγ2, PGC1α, PRDM16, and aP2 on long-term cultured 2D CCE C and ESCs grown only for 2 days (2D CCE Day 2) in which no spontaneous differentiation has occurred. In fact, Fig. 7c shows the significantly increased relative expression of PPARγ2 and aP2, both markers of adipocyte differentiation, for 2D CCE C compared to 2D CCE Day 2. In particular, PPARγ2 was dramatically increased up to 6600 fold change in 2D CCE C untreated long-term culture compared to undifferentiated 2-day ESC culture (2D CCE Day 2) ( Fig.7c) , indicating that expression of PPARγ2 in untreated 2D and 3D ES cells was a result of long-term ES cell culture itself. PRDM16 was also increased in 2D CCE C compared to 2D CCE Day 2, which reinforces its alternative role as a coactivator of PPARγ2. Notably, UCP1 did not exhibit this trend. These data indicate that long-term culture of ESCs could induce spontaneous Unser et al.
Page 9
Biomaterials. Author manuscript; available in PMC 2017 January 01.
Author Manuscript
Author Manuscript differentiation to adipocytes, but not UCP1-expressing brown adipocytes. Increased UCP1 expressions at protein and mRNA level in BMP7-induced, differentiated ESCs in alginate microstrands confirm that bioengineered "Brown-Fat-in-Microstrands" are exhibiting brown adipocyte characteristics.
Functional analysis of "Brown-Fat-in-Microstrands"
To examine whether bioengineered "Brown-fat-in-Microstrands" are functional, we evaluated their mitochondrial activity by measuring the oxygen consumption rate (OCR) using Seahorse XF Cell Mito Stress Test Kit. The "Brown-Fat-in-Microstrands" were responsive to Mito Stress challenges (Fig.S1) . The calculation showed that maximal OCR of differentiated ESCs in hydrogel microstrands went up to 200 pmol/min, which was higher than undifferentiationed ESCs in microstrands (~100 pmol/min).
We further assessed their response to the well-known β-adrenergic agonist, isoproterenol. The treatment of directly differentiated ESCs within hydrogel microstrands with 10 µM isoproterenol showed the higher relative gene expression of brown adipocyte-defining thermogenic UCP1, when compared to the untreated control ( Fig. 8 ).
Discussion
In recent years, significant efforts have been made to understand the biology of brown adipose tissue and its potential as a new therapeutic for obesity [92] [93] [94] . This could, in turn, treat a myriad of diseases caused by obesity, including type II diabetes and cardiovascular disease. However, there is an unmet need for a 3D brown adipocyte culture system that recapitulates the form and function of brown fat, both for in vitro assay development and for in vivo implantation.
To address this technical need, cell encapsulation and differentiation in alginate microstrands to create "Brown-Fat-in-Microstrands" has been established in this study, using mouse pluripotent ESC differentiation as a model system. The merit of this study lies in: 1) a new and very straightforward approach to microfluidic synthesis of alginate hydrogel microstrands for cell encapsulation; 2) 3D brown adipogenesis in alginate hydrogel microstrands; 3) direct differentiation of pluripotent stem cells into functional brown adipocytes without requiring gene transfer and/or multiple stages. The feasibility of adipogenic differentiation in alginate hydrogel microbeads has been demonstrated by human adipose-derived stromal cells, exhibiting increased lipid accumulation and adipocyte gene expression or high ratio of evenly distributed adipocytes [95, 96] . In addition, ESCs encapsulated within alginate microbeads were differentiated to release insulin, and it was confirmed that 3D differentiation systems increased insulin production over that achieved in 2D systems [97] . Mouse ESCs have also been encapsulated in alginate-poly-L-lysine microcapsules and have been exposed to a differentiation scheme leading to functional hepatocytes [98] . Although the mouse ESCs have the ability to grow within the microbeads and microcapsules, the diameter is typically just outside of the 200-µm diffusion limit, and thus, oxygen and nutrients will not be transported to the center of the cell aggregates uniformly [99] [100] [101] [102] [103] . Therefore, it is beneficial to fabricate long microstrands with diameters Unser et al.
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Author Manuscript less than 200 µm, to overcome the diffusion limit and prevent necrotic regions in the center of cell aggregates [104] while still allowing for abundant cell growth.
This study is the first to show that cells encapsulated in alginate microstrands with a liquid core can be directed to differentiate into mature brown fat, as evidenced by the accumulation of lipid droplets, expression of the brown adipocyte-defining marker UCP1 at both the protein and mRNA levels, and responsiveness to the β-adrenergic agonist with increased thermogenic UCP1 gene expression. The significance and potential of cell-laden hydrogel microfibers has been documented by reconstructing muscles, blood vessels, neural networks, and pancreatic islets in alginate-based hydrogel microfibers [77, 105, 106] as well as longterm maintenance and cryopreservation of human pluripotent stem cells [78] . Previous work has created microstrands utilizing a variety of fabrication techniques [107] [108] [109] [110] [111] [112] . One technique, in particular, encapsulated ESCs in alginate using an SU-8 filter and capillary action to create the microstrands. Mouse ESCs were cultured within the strands in both a liquid and gel interior microenvironment. The cells were shown to grow more freely and self-assemble into a high density cell mass within the liquid microenvironment, whereas cells within the gel system remained small aggregates [75] . Microstrands with an inner core of ECM proteins and a calcium-alginate hydrogel shell have also been produced using a double-coaxial laminar-flow microfluidic device [77] . These constructs allowed for effective morphology and functions including the contraction of primary myocytes and tubular shape of primary endothelial cells [77] . In this paper, we presented an efficient, straightforward microfluidic approach to cell encapsulation in alginate hydrogel microstrands by simply driving an alginate solution to flow consistently into a calcium solution.
Spontaneous differentiation of ESCs into adipocytes has been cited as a rare event [113] . However, one method that has been well established for ESCs to commit to an adipogenic lineage is to treat EBs with all-trans-retinoic acid (RA) [113, 114] . The concentration for RA is critical, however, because high concentrations of RA can cause differentiation of cells into a neural lineage in combination with other neurogenic factors [115] . Therefore, we choose a relatively low concentration (10 −8 M) of RA for initial induction. Human pluripotent stem cells have been programmed to differentiate into brown adipocytes by transducing cells with a lentiviral construct [25] . In that study, human pluripotent stem cells were first differentiated into mesenchymal progenitor cells (MPCs), and then transduced with combinations of doxycycline-inducible lentiviral constructs that encoded for the transcription factors PPARγ2, CEBPβ, and PRDM16. These transcription factors were chosen based upon previous work showing that PPARγ2 is a key regulator of adipogenesis [116] , PRDM16 can convert mouse myoblasts into brown adipocytes [32] , and a combination of CEBPβ and PRDM16 can convert mouse cells and human fibroblasts into brown adipocyte-like cells [29] . It was determined that any transcription factor combination that included PPARγ2 induced a greater expression of the brown adipocyte-defining marker UCP1 [25] . In addition, the human pluripotent stem cells-derived brown adipocytes were injected subcutaneously in vivo and analyzed after 4-6 weeks. The implanted cells stained positively for UCP1 expression. Moreover, fluorodeoxyglucose ( 18 FDG) uptake followed by positron-emission-tomography-computed tomography (PET-CT) showed that the transplanted hPSC-derived brown adipocytes had great ability to uptake FDG [25] . This is consistent with the notion that brown adipocytes act as a 'glucose sink', in that these cells are able to uptake large quantities of glucose as contribution to their vast metabolic capacity [25] . These aforementioned studies demonstrated the feasibility of differentiating of pluripotent stem cells into functional brown adipocytes. However, their reliance on gene transfer and multiple steps calls for a simplified, non-gene delivery approach to brown adipogenesis of pluripotent stem cells.
In this study, we have established a direct 3D brown adipogenesis approach by combining the microfluidic sysnthesis of alginate hydrogel microstrands for cell encapsulation with a directed differentiation of pluripotent stem cells into brown adipocytes. We first used WT-1 preadipocytes as a positive control to ensure that alginate hydrogel microstrands support preadipocyte growth, propagation, and terminal differentiation into brown adipocytes. This confirmation was determined using immunocytochemistry and qPCR analysis of brown adipocyte markers including UCP1, a brown adipocyte protein [117, 118] . A differentiation scheme was presented here based upon several studies of differentiation of ESCs into MSClike lineage, and MSCs into mature brown adipocytes [66, 88, 119] . Our results showed that ESCs could grow, propagate, and even differentiate within the alginate hydrogel microstrands. Immunocytochemistry and qPCR results confirmed the expression of brown adipocyte markers including brown adipocyte-defining UCP1. Functional analysis confirmed the ESC-derived 3D "Brown-Fat-in-Microstrands" responded to the β-adrenergic agonist, isoproterenol to upregulate the gene expression of thermogenic UCP1, which demonstrates the feasibility of these constructs to exert thermogenic activity and serve as an in vitro drug-screening platform.
Furthermore, the degree of ESC differentiation within the 3D alginate hydrogel microstrands was compared to that in a traditional 2D system. A qPCR analysis showed that ESCs differentiated in 3D expressed UCP1, PRDM16, PGC1α and aP2 at higher levels than ESCs differentiated in 2D. This finding is consistent with literature reports that have shown 3D differentiation of pluripotent stem cells are more effective than 2D, by preferable representation of an in vivo system with improved scalability [66, 76, 120, 121] .
Altogether, this study demonstrates the feasibility of 3D adipogenesis of pluripotent stem cells to construct functional "Brown-Fat-in-Microstrands", which has great potential for in vitro analyses and in vivo implantation.
Conclusions
Preadipocytes and ESCs can be successfully encapsulated, grown, and differentiated into brown adipocytes within 3D alginate hydrogel microstrands, forming "Brown-Fat-in-Microstrands" that express the brown adipocyte-defining marker UCP1 and exhibit characteristic brown adipocyte activation in response to β-adrenergic agonists. A higher level of gene expression of the brown adipocyte marker UCP1, in ESCs differentiated in 3D hydrogel microstrands than the traditional 2D culture system, indicated 3D adipogenesis is more efficient than 2D. Future work will explore using the ESC-differentiated "Brown-Fatin-Microstrands" to understand early events during brown adipogenesis, to test potential obesity agents, and determine the feasibility of in vivo implantation. Biomaterials. Author manuscript; available in PMC 2017 January 01.
